The company reported a 7% decline in profit to $170 million, or $1.40 cents per diluted share, 5 cents better than analyst expectations.
Revenue for the quarter was down 2% from the year ago period to $1.51 billion, slightly ahead of analysts expectations of $1.50 billion.
TheStreet Ratings team rates CLOROX CO/DE as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate CLOROX CO/DE (CLX) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its increase in net income, notable return on equity, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated."